Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Phase I data reported for antitumor bisnaphthalimide DMP-840

April 21, 1998

Tricyclic compounds inhibiting protein farnesyltransferase claimed by Schering-Plough

April 21, 1998

mRNA splicing appears to trigger metastasis in prostate cancer

April 21, 1998

RPR's Gliadel Wafer approved in Argentina

April 20, 1998

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

April 20, 1998

Synthetic dolastatin derivatives as antitumor agents

April 20, 1998

Idun seeks licensing partners for apoptosis regulators

April 20, 1998

SuperGen's Nipent granted orphan drug status

April 17, 1998

Another CS-A4 derivative discovered by Ajinomoto

April 17, 1998

Novel polymer chemotherapeutic presented at ACS meeting

April 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...
Korea targets generics, innovation in drug pricing overhaul
BioWorld
South Korea is moving ahead with its biggest reform of drug review and pricing in more than a decade, reflecting a wider shift across Asian markets to reward...